Clinical Trials Browser

OTHER × Lymphoma, T-Cell, Peripheral × fludarabine × Clear all

Lymphoma, Lymphoma, T-Cell, Peripheral

NCT02512497 2025-09-19

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06468267 2024-08-01

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

Phase 2 Recruiting

50 enrolled

Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00840385 2010-09-15

FAD

Phase 2 Unknown

30 enrolled

Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Clinical Trials

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

FAD